Nonprofit · EIN 36-4825921
THE MARK FOUNDATION FOR CANCER RESEARCH US LTD
Tax-exempt · NEW YORK, NY 10019
Financials
| Year ended | Form | Revenue | Expenses | Net income | Total assets | Liabilities | Net assets |
|---|---|---|---|---|---|---|---|
| December 31, 2024 | 990 | $44,772,901 | $36,066,750 | $8,706,151 | $105,459,714 | $13,019,944 | $92,439,770 |
| December 31, 2023 | 990 | $40,937,632 | $35,209,497 | $5,728,135 | $104,492,388 | $20,015,419 | $84,476,969 |
Financial details: 990 for the year ended December 31, 2024
Revenue
- Contributions, gifts and grants
- $44,393,676
- Program service revenue
- $0
- Investment income
- $409,872
- Net gain from sales of assets
- -$298,330
- Other revenue
- -$30,647
Expenses
- Grants and similar amounts paid
- $30,533,067
- Compensation of officers, directors and key employees
- $1,695,809
- Other salaries and wages
- $621,680
- Salaries, compensation and benefits (total)
- $2,662,168
- Professional fundraising fees
- $0
- Legal fees
- $246,685
- Accounting fees
- $251,079
- Occupancy
- $407,932
- Travel
- $243,551
- Depreciation
- $104,950
- Program services (functional)
- $33,898,449
- Management and general (functional)
- $1,152,756
- Fundraising (functional)
- $1,015,545
Balance sheet and other
- Total assets, start of year
- $104,492,388
- Total assets, end of year
- $105,459,714
- Total liabilities, end of year
- $13,019,944
- Net assets, end of year
- $92,439,770
- Land, buildings and equipment
- $53,431
- Publicly traded securities
- $12,298,546
- Net assets without donor restrictions
- $83,738,330
- Net assets with donor restrictions
- $8,701,440
- Gross receipts
- $48,526,753
- Employees
- 9
- Volunteers
- 11
- Year formed
- 2015
- State of legal domicile
- NY
From the e-filed returns the IRS publishes as XML (latest three processing years; amended returns replace the original). PDF copies at the IRS.
Officers, directors and key employees
As listed on the 990 for the year ended December 31, 2024, highest compensation first.
| Name | Title | Hours / week | Compensation | Other / benefits |
|---|---|---|---|---|
| RYAN SCHOENFELD | CHIEF EXECUTIVE OFFICER Officer | 40 | $506,697 | $54,667 |
| RAYMOND DUBOIS | EXECUTIVE CHAIRMAN OF THE BOARD Trustee or director, Officer | 24 | $560,000 | $0 |
| REBECCA BISH-CORNELISSEN | HEAD DISCOVERY/PRE-CLINICAL RESEARCH Highest-paid employee | 40 | $310,646 | $51,139 |
| ANNA TURETSKY TO 724 | PRINCIPAL, VENTURE INVESTMENTS Key employee | 40 | $327,122 | $21,607 |
| AMY FEHIR | HEAD OF DEVELOPMENT Highest-paid employee | 40 | $215,995 | $30,535 |
| REBECCA LIU | DIRECTOR, GRANTS ADMINISTRATION Highest-paid employee | 40 | $197,094 | $34,568 |
| MICHAEL CARLETON | SENIOR SCIENTIFIC DIRECTOR Highest-paid employee | 40 | $175,776 | $47,706 |
| IAN LESSER | DIRECTOR FINANCE & ADMINISTRATION Officer | 40 | $172,733 | $42,983 |
| ROBERT MAGIN | ASSOCIATE SCIENTIFIC DIRECTOR Highest-paid employee | 40 | $169,179 | $20,443 |
| ROSS LEVINE | DIRECTOR Trustee or director | 1 | $10,000 | $0 |
| ALEX KNASTER | DIRECTOR Trustee or director | 1 | $0 | $0 |
| NICOLA MENDEHLSON | DIRECTOR Trustee or director | 1 | $0 | $0 |
| PAUL POSPISIL | DIRECTOR Trustee or director | 1 | $0 | $0 |
| OTMAR D WIESTLER | DIRECTOR Trustee or director | 1 | $0 | $0 |
990 for the year ended December 31, 2023: 18 people
| Name | Title | Hours / week | Compensation | Other / benefits |
|---|---|---|---|---|
| RAYMOND DUBOIS | EXECUTIVE CHAIRMAN OF THE BOARD Trustee or director, Officer | 24 | $560,000 | $0 |
| RYAN SCHOENFELD | CHIEF EXECUTIVE OFFICER Officer | 40 | $486,888 | $67,648 |
| REBECCA BISH-CORNELISSEN | HEAD DISCOVERY/PRECLINICAL RESEARCH Highest-paid employee | 40 | $310,138 | $58,907 |
| ANNA TURETSKY | PRINCIPAL, VENTURE INVESTMENTS Key employee | 40 | $291,748 | $62,324 |
| S PATRICK LEWIS TO 923 | HEAD OF FINANCE AND OPERATIONS Officer | 40 | $210,970 | $54,124 |
| REBECCA LIU | DIRECTOR, GRANTS ADMINISTRATION Highest-paid employee | 40 | $182,444 | $41,050 |
| JANICE LIN | PORTFOLIO MGR, RESEARCH/INVESTMENTS Highest-paid employee | 40 | $144,253 | $24,814 |
| ROBERT MAGIN | ASSOCIATE SCIENTIFIC DIRECTOR Highest-paid employee | 40 | $141,590 | $24,633 |
| AMY FEHIR | HEAD OF DEVELOPMENT Highest-paid employee | 40 | $106,825 | $19,706 |
| IAN LESSER AS OF 723 | DIRECTOR FINANCE & ADMINISTRATION Officer | 40 | $67,083 | $27,777 |
| ROSS LEVINE | DIRECTOR Trustee or director | 1 | $10,000 | $0 |
| ALEX KNASTER AS OF 423 | DIRECTOR Trustee or director | 1 | $0 | $0 |
| NICOLA MENDEHLSON AS OF 523 | DIRECTOR Trustee or director | 1 | $0 | $0 |
| PAUL POSPISIL | DIRECTOR Trustee or director | 1 | $0 | $0 |
| OTMAR D WIESTLER AS OF 52023 | DIRECTOR Trustee or director | 1 | $0 | $0 |
| STUART THOMSON TO 323 | DIRECTOR Trustee or director | 1 | $0 | $0 |
| KEVIN O'FLAHERTY TO 323 | DIRECTOR Trustee or director | 1 | $0 | $0 |
| WILLIAM SHAPARD TO 423 | DIRECTOR Trustee or director | 1 | $0 | $0 |
Address and contacts
- Address (IRS master file)
- 1350 AVENUE OF THE AMERICAS 2902, NEW YORK, NY 10019-4738
- In care of
- % S PATRICK LEWIS
- Principal officer (990 for 2024)
- RYAN SCHOENFELD, 1350 AVENUE OF THE AMERICAS 2902, NEW YORK, NY 10019
- Signed the 990
- RYAN SCHOENFELD, CEO
- Phone
- (646) 866-5950
- Website
- WWW.THEMARKFOUNDATION.ORG
- Return prepared by
- EISNER ADVISORY GROUP LLC
Mission
PARTNER WITH SCIENTISTS TO ACCELERATE RESEARCH THAT WILL TRANSFORM THE PREVENTION, DIAGNOSIS, AND TREATMENT OF CANCER THROUGH GROUND BREAKING SCIENCE CARRIED OUT BY INDIVIDUAL INVESTIGATORS, MULTIDISCIPLINARY TEAMS, AND EARLY STAGE COMPANIES IN THE U.S AND ABROAD.
Program accomplishments
- THE FOUNDATION'S GRANTS REWARD INNOVATIVE THINKING THAT ADVANCES THE UNDERSTANDING OF CANCER BIOLOGY AND IMPROVES ONCOLOGY TREATMENT PARADIGMS. THE FOUNDATION SUPPORTS INDIVIDUAL INVESTIGATORS, AS WELL AS MULTIDISCIPLINARY COLLABORATIVE TEAMS CONDUCTING RESEARCH ACROSS CANCER TYPES. THE GRANTEES BECOME PART OF THE FOUNDATION'S NETWORK OF THE BEST SCIENTIFIC MINDS IN CANCER RESEARCH AND TECHNOLOGICAL INNOVATION. GRANT SUBMISSIONS UNDERGO RIGOROUS PEER REVIEW BY THE FOUNDATION'S SCIENTIFIC ADVISORY COMMITTEE OR RECOMMENDED SUBJECT MATTER EXPERTS AND ARE HELD TO THE STRICTEST STANDARDS OF SCIENTIFIC EXCELLENCE.Expenses $33,898,449 · grants $30,533,067
What it must file and when
IRS records say it files Form 990 or 990-EZ. Based on its last return; a smaller organization may file the 990-N. Its accounting year ends in December, so each return is due on the 15th day of the 5th month after that.
| Tax year | Year ended | Due | IRS public records |
|---|---|---|---|
| 2025 | December 31, 2025 | May 15, 2026 | Not on file |
| 2024 | December 31, 2024 | May 15, 2025 | 990 on file |
| 2023 | December 31, 2023 | May 15, 2024 | 990 on file |
IRS record
- EIN
- 36-4825921
- Tax-exempt status
- 501(c)(3): Charitable, religious, educational or scientific organization
- Foundation status
- Publicly supported organization (170(b)(1)(A)(vi))
- Donations deductible (Pub 78)
- Public charity, 50% deduction limit
- Exempt since
- 2016
- Accounting year ends
- December
- Files
- Form 990 or 990-EZ
- Category (NTEE)
- Voluntary health associations and medical disciplines (G30)
- Assets (IRS master file)
- $105,459,714
- Income (IRS master file)
- $48,526,753
Filing history
| Form | Year ended | Revenue | Expenses | Assets | Return |
|---|---|---|---|---|---|
| 990 | December 2024 | $44,772,901 | $36,066,750 | $105,459,714 | XML |
| 990 | December 2023 | $40,937,632 | $35,209,497 | $104,492,388 | XML |
| 990 | December 2022 | $55,345,494 | $38,014,606 | $110,652,350 | IRS |
| 990 | December 2021 | – | – | – | IRS |
| 990 | December 2020 | – | – | – | IRS |
| 990 | December 2019 | – | – | – | IRS |
| 990 | December 2018 | – | – | – | IRS |
990-N: the IRS bulk file holds only the latest e-Postcard per organization; earlier years come from archived copies of that file since 2020 and can have gaps (the IRS e-Postcard search lists every one). 990, 990-EZ, 990-PF, 990-T: every e-filed return in the IRS e-file index since 2019; XML for the latest three processing years, amounts from the IRS Statistics of Income extracts before that. PDF copies and determination letters at the IRS (search EIN 36-4825921).
Questions about THE MARK FOUNDATION FOR CANCER RESEARCH US LTD
- What is the EIN of THE MARK FOUNDATION FOR CANCER RESEARCH US LTD?
- The employer identification number (EIN) of THE MARK FOUNDATION FOR CANCER RESEARCH US LTD is 36-4825921.
- Is THE MARK FOUNDATION FOR CANCER RESEARCH US LTD tax-exempt?
- Yes. The IRS lists it as tax-exempt under section 501(c)(3) since 2016.
- Are donations to THE MARK FOUNDATION FOR CANCER RESEARCH US LTD tax-deductible?
- Yes. It is listed in IRS Publication 78 (Public charity, 50% deduction limit).
- Which annual return does THE MARK FOUNDATION FOR CANCER RESEARCH US LTD file?
- Form 990 or 990-EZ. Based on its last return; a smaller organization may file the 990-N.
- When is the next return of THE MARK FOUNDATION FOR CANCER RESEARCH US LTD due?
- The return for tax year 2025 (the year ending December 31, 2025) is due May 15, 2026. Form 8868 extends it by six months; the 990-N cannot be extended.
- When did THE MARK FOUNDATION FOR CANCER RESEARCH US LTD last file with the IRS?
- The latest return in the IRS public files is the 990 for the year ended December 2024.
- Who is the principal officer of THE MARK FOUNDATION FOR CANCER RESEARCH US LTD?
- The 990 for the year ended December 31, 2024 names RYAN SCHOENFELD.
- Who are the officers and directors of THE MARK FOUNDATION FOR CANCER RESEARCH US LTD?
- The 990 for the year ended December 31, 2024 lists 14 people; 10 received compensation from the organization, the highest $506,697 (RYAN SCHOENFELD, CHIEF EXECUTIVE OFFICER).
- How much revenue does THE MARK FOUNDATION FOR CANCER RESEARCH US LTD have?
- On its 990 for the year ended December 31, 2024 it reported revenue of $44,772,901, expenses of $36,066,750 and total assets of $105,459,714 at year end.
Other nonprofits in NEW YORK
- BREAKTHROUGH T1D EIN 23-1907729 · last filed 990 for 2025
- UNITED CEREBRAL PALSY ASSOCIATIONS OF NEW YORK STATE INC EIN 13-1623856 · last filed 990 for 2025
- UNITED CEREBRAL PALSY OF NEW YORK CITY INC EIN 13-5654532 · last filed 990 for 2025
- NATIONAL MULTIPLE SCLEROSIS SOCIETY EIN 13-5661935 · last filed 990 for 2025
- FUND FOR PUBLIC HEALTH IN NEW YORK INC EIN 05-0539199 · last filed 990 for 2025
- CROHNS & COLITIS FOUNDATION INC EIN 13-6193105 · last filed 990 for 2024
- NATIONAL KIDNEY FOUNDATION INC EIN 13-1673104 · last filed 990 for 2025
- APICHA COMMUNITY HEALTH CENTER EIN 13-3706365 · last filed 990 for 2025
All nonprofits in NEW YORK · New York · Voluntary health associations and medical disciplines